epigenetics
The Canadian company plans to test the clinical utility of its targeted 90-marker panel in monitoring patient response to therapy.
The grant was recently awarded through the EU's Cancer Mission, a funding program to reduce cancer cases throughout the EU by 2030.
SeekIn Receives CE-IVD Mark for Cancer Recurrence Monitoring Test
The company's SeekInCure pan-cancer assay detects minimal residual disease in patient blood samples and has been validated in hepatocellular carcinoma.
The firm uses epigenetic and genetic information, along with machine learning to determine a patient's risk of cardiovascular disease.
European Team Publishes Molecular Endometrial Cancer Test; Startup Sola Dx Plans Fall Launch
Premium
Called WID-qEC, the test uses quantitative PCR methylation profiling to diagnose endometrial cancer in women presenting with symptoms.
Jul 18, 2022
Delfi Diagnostics Raises $225M in Series B Financing
May 31, 2022
Cardio Diagnostics to Go Public via Merger With SPAC
May 31, 2022
VolitionRx Gets CE Mark for NETosis Test
Apr 15, 2021
Jan 11, 2021